Compugen (NASDAQ:CGEN) Downgraded to Hold Rating by StockNews.com
Compugen (NASDAQ:CGEN – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, ...
Nasdaq7d
Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates
Compugen (CGEN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.07. This compares to earnings of $0.11 per share a year ago. These figures are adjusted ...
Zacks.com on MSN7d
Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates
Compugen (CGEN) delivered earnings and revenue surprises of -200% and 91.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Truist Financial Reaffirms Their Buy Rating on Compugen (CGEN)
Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Compugen (CGEN – Research Report) today. The company’s shares closed ...
My Top 3 Dividend-Paying Buy-And-Hold Stocks For 2025: Combining Income & Growth
In today’s article, I will present you with my top three dividend-paying buy-and-hold companies for 2025, which can help you ...
If I Could Only Buy and Hold a Single Stock, This Would Be It.
Choosing a single stock to buy and hold isn't an easy task. So many factors come into play, such as company longevity, innovation, and competition. Furthermore, you also want to ensure that the ...